Global Tumor Ablation Market Size, Status and Forecast 2020-2026
This is a minimally invasive surgical method to treat solid cancers, Special probes are used to “burn” or “freeze” cancers without the usual surgery. Computed Tomography (CT), Ultrasound (US) or Magnetic Resonance Imaging (MRI) is used to guide and position the needle probe into the tumor. This requires only a tiny hole, usually less than 3 mm via which the probe is introduced. When the probe is within the cancer it is attached to a generator which “burns” or “freezes” the cancer.
The United States average price of Tumor Ablation is in the decreasing trend, from 410 K USD/ Unit in 2011 to 403.6 K USD/Unit in 2015. With the situation of United States economy, prices will be in decreasing trend in the following five years.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Tumor Ablation market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Tumor Ablation industry.
Based on our recent survey, we have several different scenarios about the Tumor Ablation YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Tumor Ablation will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Tumor Ablation market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Tumor Ablation market in terms of revenue.
Players, stakeholders, and other participants in the global Tumor Ablation market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Tumor Ablation market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Tumor Ablation market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Tumor Ablation market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Tumor Ablation market.
The following players are covered in this report:
The United States average price of Tumor Ablation is in the decreasing trend, from 410 K USD/ Unit in 2011 to 403.6 K USD/Unit in 2015. With the situation of United States economy, prices will be in decreasing trend in the following five years.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Tumor Ablation market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Tumor Ablation industry.
Based on our recent survey, we have several different scenarios about the Tumor Ablation YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Tumor Ablation will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Tumor Ablation market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Tumor Ablation market in terms of revenue.
Players, stakeholders, and other participants in the global Tumor Ablation market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Tumor Ablation market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Tumor Ablation market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Tumor Ablation market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Tumor Ablation market.
The following players are covered in this report:
- Angiodynamics
- Medtronic
- Boston Scientific
- Galil Medical
- Neuwave Medical
- Misonix
- Merit Medical
- Sonacare Medical
- EDAP TMS
- Radiofrequency (RF) Ablation
- Microwave Ablation
- Cryoablation
- Other Technologies
- Liver Cancer
- Lung Cancer
- Kidney Cancer
- Others
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Tumor Ablation Revenue
1.4 Market Analysis by Type
1.4.1 Global Tumor Ablation Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Radiofrequency (RF) Ablation
1.4.3 Microwave Ablation
1.4.4 Cryoablation
1.4.5 Other Technologies
1.5 Market by Application
1.5.1 Global Tumor Ablation Market Share by Application: 2020 VS 2026
1.5.2 Liver Cancer
1.5.3 Lung Cancer
1.5.4 Kidney Cancer
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Tumor Ablation Industry Impact
1.6.1 How the Covid-19 is Affecting the Tumor Ablation Industry
1.6.1.1 Tumor Ablation Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Tumor Ablation Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Tumor Ablation Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Tumor Ablation Market Perspective (2015-2026)
2.2 Tumor Ablation Growth Trends by Regions
2.2.1 Tumor Ablation Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Tumor Ablation Historic Market Share by Regions (2015-2020)
2.2.3 Tumor Ablation Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Tumor Ablation Market Growth Strategy
2.3.6 Primary Interviews with Key Tumor Ablation Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Tumor Ablation Players by Market Size
3.1.1 Global Top Tumor Ablation Players by Revenue (2015-2020)
3.1.2 Global Tumor Ablation Revenue Market Share by Players (2015-2020)
3.1.3 Global Tumor Ablation Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Tumor Ablation Market Concentration Ratio
3.2.1 Global Tumor Ablation Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Tumor Ablation Revenue in 2019
3.3 Tumor Ablation Key Players Head office and Area Served
3.4 Key Players Tumor Ablation Product Solution and Service
3.5 Date of Enter into Tumor Ablation Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Tumor Ablation Historic Market Size by Type (2015-2020)
4.2 Global Tumor Ablation Forecasted Market Size by Type (2021-2026)
5 TUMOR ABLATION BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Tumor Ablation Market Size by Application (2015-2020)
5.2 Global Tumor Ablation Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Tumor Ablation Market Size (2015-2020)
6.2 Tumor Ablation Key Players in North America (2019-2020)
6.3 North America Tumor Ablation Market Size by Type (2015-2020)
6.4 North America Tumor Ablation Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Tumor Ablation Market Size (2015-2020)
7.2 Tumor Ablation Key Players in Europe (2019-2020)
7.3 Europe Tumor Ablation Market Size by Type (2015-2020)
7.4 Europe Tumor Ablation Market Size by Application (2015-2020)
8 CHINA
8.1 China Tumor Ablation Market Size (2015-2020)
8.2 Tumor Ablation Key Players in China (2019-2020)
8.3 China Tumor Ablation Market Size by Type (2015-2020)
8.4 China Tumor Ablation Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Tumor Ablation Market Size (2015-2020)
9.2 Tumor Ablation Key Players in Japan (2019-2020)
9.3 Japan Tumor Ablation Market Size by Type (2015-2020)
9.4 Japan Tumor Ablation Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Tumor Ablation Market Size (2015-2020)
10.2 Tumor Ablation Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Tumor Ablation Market Size by Type (2015-2020)
10.4 Southeast Asia Tumor Ablation Market Size by Application (2015-2020)
11 INDIA
11.1 India Tumor Ablation Market Size (2015-2020)
11.2 Tumor Ablation Key Players in India (2019-2020)
11.3 India Tumor Ablation Market Size by Type (2015-2020)
11.4 India Tumor Ablation Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Tumor Ablation Market Size (2015-2020)
12.2 Tumor Ablation Key Players in Central & South America (2019-2020)
12.3 Central & South America Tumor Ablation Market Size by Type (2015-2020)
12.4 Central & South America Tumor Ablation Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Angiodynamics
13.1.1 Angiodynamics Company Details
13.1.2 Angiodynamics Business Overview and Its Total Revenue
13.1.3 Angiodynamics Tumor Ablation Introduction
13.1.4 Angiodynamics Revenue in Tumor Ablation Business (2015-2020))
13.1.5 Angiodynamics Recent Development
13.2 Medtronic
13.2.1 Medtronic Company Details
13.2.2 Medtronic Business Overview and Its Total Revenue
13.2.3 Medtronic Tumor Ablation Introduction
13.2.4 Medtronic Revenue in Tumor Ablation Business (2015-2020)
13.2.5 Medtronic Recent Development
13.3 Boston Scientific
13.3.1 Boston Scientific Company Details
13.3.2 Boston Scientific Business Overview and Its Total Revenue
13.3.3 Boston Scientific Tumor Ablation Introduction
13.3.4 Boston Scientific Revenue in Tumor Ablation Business (2015-2020)
13.3.5 Boston Scientific Recent Development
13.4 Galil Medical
13.4.1 Galil Medical Company Details
13.4.2 Galil Medical Business Overview and Its Total Revenue
13.4.3 Galil Medical Tumor Ablation Introduction
13.4.4 Galil Medical Revenue in Tumor Ablation Business (2015-2020)
13.4.5 Galil Medical Recent Development
13.5 Neuwave Medical
13.5.1 Neuwave Medical Company Details
13.5.2 Neuwave Medical Business Overview and Its Total Revenue
13.5.3 Neuwave Medical Tumor Ablation Introduction
13.5.4 Neuwave Medical Revenue in Tumor Ablation Business (2015-2020)
13.5.5 Neuwave Medical Recent Development
13.6 Misonix
13.6.1 Misonix Company Details
13.6.2 Misonix Business Overview and Its Total Revenue
13.6.3 Misonix Tumor Ablation Introduction
13.6.4 Misonix Revenue in Tumor Ablation Business (2015-2020)
13.6.5 Misonix Recent Development
13.7 Merit Medical
13.7.1 Merit Medical Company Details
13.7.2 Merit Medical Business Overview and Its Total Revenue
13.7.3 Merit Medical Tumor Ablation Introduction
13.7.4 Merit Medical Revenue in Tumor Ablation Business (2015-2020)
13.7.5 Merit Medical Recent Development
13.8 Sonacare Medical
13.8.1 Sonacare Medical Company Details
13.8.2 Sonacare Medical Business Overview and Its Total Revenue
13.8.3 Sonacare Medical Tumor Ablation Introduction
13.8.4 Sonacare Medical Revenue in Tumor Ablation Business (2015-2020)
13.8.5 Sonacare Medical Recent Development
13.9 EDAP TMS
13.9.1 EDAP TMS Company Details
13.9.2 EDAP TMS Business Overview and Its Total Revenue
13.9.3 EDAP TMS Tumor Ablation Introduction
13.9.4 EDAP TMS Revenue in Tumor Ablation Business (2015-2020)
13.9.5 EDAP TMS Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Tumor Ablation Revenue
1.4 Market Analysis by Type
1.4.1 Global Tumor Ablation Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Radiofrequency (RF) Ablation
1.4.3 Microwave Ablation
1.4.4 Cryoablation
1.4.5 Other Technologies
1.5 Market by Application
1.5.1 Global Tumor Ablation Market Share by Application: 2020 VS 2026
1.5.2 Liver Cancer
1.5.3 Lung Cancer
1.5.4 Kidney Cancer
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Tumor Ablation Industry Impact
1.6.1 How the Covid-19 is Affecting the Tumor Ablation Industry
1.6.1.1 Tumor Ablation Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Tumor Ablation Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Tumor Ablation Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Tumor Ablation Market Perspective (2015-2026)
2.2 Tumor Ablation Growth Trends by Regions
2.2.1 Tumor Ablation Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Tumor Ablation Historic Market Share by Regions (2015-2020)
2.2.3 Tumor Ablation Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Tumor Ablation Market Growth Strategy
2.3.6 Primary Interviews with Key Tumor Ablation Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Tumor Ablation Players by Market Size
3.1.1 Global Top Tumor Ablation Players by Revenue (2015-2020)
3.1.2 Global Tumor Ablation Revenue Market Share by Players (2015-2020)
3.1.3 Global Tumor Ablation Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Tumor Ablation Market Concentration Ratio
3.2.1 Global Tumor Ablation Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Tumor Ablation Revenue in 2019
3.3 Tumor Ablation Key Players Head office and Area Served
3.4 Key Players Tumor Ablation Product Solution and Service
3.5 Date of Enter into Tumor Ablation Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Tumor Ablation Historic Market Size by Type (2015-2020)
4.2 Global Tumor Ablation Forecasted Market Size by Type (2021-2026)
5 TUMOR ABLATION BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Tumor Ablation Market Size by Application (2015-2020)
5.2 Global Tumor Ablation Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Tumor Ablation Market Size (2015-2020)
6.2 Tumor Ablation Key Players in North America (2019-2020)
6.3 North America Tumor Ablation Market Size by Type (2015-2020)
6.4 North America Tumor Ablation Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Tumor Ablation Market Size (2015-2020)
7.2 Tumor Ablation Key Players in Europe (2019-2020)
7.3 Europe Tumor Ablation Market Size by Type (2015-2020)
7.4 Europe Tumor Ablation Market Size by Application (2015-2020)
8 CHINA
8.1 China Tumor Ablation Market Size (2015-2020)
8.2 Tumor Ablation Key Players in China (2019-2020)
8.3 China Tumor Ablation Market Size by Type (2015-2020)
8.4 China Tumor Ablation Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Tumor Ablation Market Size (2015-2020)
9.2 Tumor Ablation Key Players in Japan (2019-2020)
9.3 Japan Tumor Ablation Market Size by Type (2015-2020)
9.4 Japan Tumor Ablation Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Tumor Ablation Market Size (2015-2020)
10.2 Tumor Ablation Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Tumor Ablation Market Size by Type (2015-2020)
10.4 Southeast Asia Tumor Ablation Market Size by Application (2015-2020)
11 INDIA
11.1 India Tumor Ablation Market Size (2015-2020)
11.2 Tumor Ablation Key Players in India (2019-2020)
11.3 India Tumor Ablation Market Size by Type (2015-2020)
11.4 India Tumor Ablation Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Tumor Ablation Market Size (2015-2020)
12.2 Tumor Ablation Key Players in Central & South America (2019-2020)
12.3 Central & South America Tumor Ablation Market Size by Type (2015-2020)
12.4 Central & South America Tumor Ablation Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Angiodynamics
13.1.1 Angiodynamics Company Details
13.1.2 Angiodynamics Business Overview and Its Total Revenue
13.1.3 Angiodynamics Tumor Ablation Introduction
13.1.4 Angiodynamics Revenue in Tumor Ablation Business (2015-2020))
13.1.5 Angiodynamics Recent Development
13.2 Medtronic
13.2.1 Medtronic Company Details
13.2.2 Medtronic Business Overview and Its Total Revenue
13.2.3 Medtronic Tumor Ablation Introduction
13.2.4 Medtronic Revenue in Tumor Ablation Business (2015-2020)
13.2.5 Medtronic Recent Development
13.3 Boston Scientific
13.3.1 Boston Scientific Company Details
13.3.2 Boston Scientific Business Overview and Its Total Revenue
13.3.3 Boston Scientific Tumor Ablation Introduction
13.3.4 Boston Scientific Revenue in Tumor Ablation Business (2015-2020)
13.3.5 Boston Scientific Recent Development
13.4 Galil Medical
13.4.1 Galil Medical Company Details
13.4.2 Galil Medical Business Overview and Its Total Revenue
13.4.3 Galil Medical Tumor Ablation Introduction
13.4.4 Galil Medical Revenue in Tumor Ablation Business (2015-2020)
13.4.5 Galil Medical Recent Development
13.5 Neuwave Medical
13.5.1 Neuwave Medical Company Details
13.5.2 Neuwave Medical Business Overview and Its Total Revenue
13.5.3 Neuwave Medical Tumor Ablation Introduction
13.5.4 Neuwave Medical Revenue in Tumor Ablation Business (2015-2020)
13.5.5 Neuwave Medical Recent Development
13.6 Misonix
13.6.1 Misonix Company Details
13.6.2 Misonix Business Overview and Its Total Revenue
13.6.3 Misonix Tumor Ablation Introduction
13.6.4 Misonix Revenue in Tumor Ablation Business (2015-2020)
13.6.5 Misonix Recent Development
13.7 Merit Medical
13.7.1 Merit Medical Company Details
13.7.2 Merit Medical Business Overview and Its Total Revenue
13.7.3 Merit Medical Tumor Ablation Introduction
13.7.4 Merit Medical Revenue in Tumor Ablation Business (2015-2020)
13.7.5 Merit Medical Recent Development
13.8 Sonacare Medical
13.8.1 Sonacare Medical Company Details
13.8.2 Sonacare Medical Business Overview and Its Total Revenue
13.8.3 Sonacare Medical Tumor Ablation Introduction
13.8.4 Sonacare Medical Revenue in Tumor Ablation Business (2015-2020)
13.8.5 Sonacare Medical Recent Development
13.9 EDAP TMS
13.9.1 EDAP TMS Company Details
13.9.2 EDAP TMS Business Overview and Its Total Revenue
13.9.3 EDAP TMS Tumor Ablation Introduction
13.9.4 EDAP TMS Revenue in Tumor Ablation Business (2015-2020)
13.9.5 EDAP TMS Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. Tumor Ablation Key Market Segments
Table 2. Key Players Covered: Ranking by Tumor Ablation Revenue
Table 3. Ranking of Global Top Tumor Ablation Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Tumor Ablation Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Radiofrequency (RF) Ablation
Table 6. Key Players of Microwave Ablation
Table 7. Key Players of Cryoablation
Table 8. Key Players of Other Technologies
Table 9. COVID-19 Impact Global Market: (Four Tumor Ablation Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Tumor Ablation Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Tumor Ablation Players to Combat Covid-19 Impact
Table 14. Global Tumor Ablation Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Tumor Ablation Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Tumor Ablation Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Tumor Ablation Market Share by Regions (2015-2020)
Table 18. Global Tumor Ablation Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Tumor Ablation Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Tumor Ablation Market Growth Strategy
Table 24. Main Points Interviewed from Key Tumor Ablation Players
Table 25. Global Tumor Ablation Revenue by Players (2015-2020) (Million US$)
Table 26. Global Tumor Ablation Market Share by Players (2015-2020)
Table 27. Global Top Tumor Ablation Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tumor Ablation as of 2019)
Table 28. Global Tumor Ablation by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Tumor Ablation Product Solution and Service
Table 31. Date of Enter into Tumor Ablation Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Tumor Ablation Market Size by Type (2015-2020) (Million US$)
Table 34. Global Tumor Ablation Market Size Share by Type (2015-2020)
Table 35. Global Tumor Ablation Revenue Market Share by Type (2021-2026)
Table 36. Global Tumor Ablation Market Size Share by Application (2015-2020)
Table 37. Global Tumor Ablation Market Size by Application (2015-2020) (Million US$)
Table 38. Global Tumor Ablation Market Size Share by Application (2021-2026)
Table 39. North America Key Players Tumor Ablation Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Tumor Ablation Market Share (2019-2020)
Table 41. North America Tumor Ablation Market Size by Type (2015-2020) (Million US$)
Table 42. North America Tumor Ablation Market Share by Type (2015-2020)
Table 43. North America Tumor Ablation Market Size by Application (2015-2020) (Million US$)
Table 44. North America Tumor Ablation Market Share by Application (2015-2020)
Table 45. Europe Key Players Tumor Ablation Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Tumor Ablation Market Share (2019-2020)
Table 47. Europe Tumor Ablation Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Tumor Ablation Market Share by Type (2015-2020)
Table 49. Europe Tumor Ablation Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Tumor Ablation Market Share by Application (2015-2020)
Table 51. China Key Players Tumor Ablation Revenue (2019-2020) (Million US$)
Table 52. China Key Players Tumor Ablation Market Share (2019-2020)
Table 53. China Tumor Ablation Market Size by Type (2015-2020) (Million US$)
Table 54. China Tumor Ablation Market Share by Type (2015-2020)
Table 55. China Tumor Ablation Market Size by Application (2015-2020) (Million US$)
Table 56. China Tumor Ablation Market Share by Application (2015-2020)
Table 57. Japan Key Players Tumor Ablation Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Tumor Ablation Market Share (2019-2020)
Table 59. Japan Tumor Ablation Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Tumor Ablation Market Share by Type (2015-2020)
Table 61. Japan Tumor Ablation Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Tumor Ablation Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Tumor Ablation Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Tumor Ablation Market Share (2019-2020)
Table 65. Southeast Asia Tumor Ablation Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Tumor Ablation Market Share by Type (2015-2020)
Table 67. Southeast Asia Tumor Ablation Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Tumor Ablation Market Share by Application (2015-2020)
Table 69. India Key Players Tumor Ablation Revenue (2019-2020) (Million US$)
Table 70. India Key Players Tumor Ablation Market Share (2019-2020)
Table 71. India Tumor Ablation Market Size by Type (2015-2020) (Million US$)
Table 72. India Tumor Ablation Market Share by Type (2015-2020)
Table 73. India Tumor Ablation Market Size by Application (2015-2020) (Million US$)
Table 74. India Tumor Ablation Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Tumor Ablation Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Tumor Ablation Market Share (2019-2020)
Table 77. Central & South America Tumor Ablation Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Tumor Ablation Market Share by Type (2015-2020)
Table 79. Central & South America Tumor Ablation Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Tumor Ablation Market Share by Application (2015-2020)
Table 81. Angiodynamics Company Details
Table 82. Angiodynamics Business Overview
Table 83. Angiodynamics Product
Table 84. Angiodynamics Revenue in Tumor Ablation Business (2015-2020) (Million US$)
Table 85. Angiodynamics Recent Development
Table 86. Medtronic Company Details
Table 87. Medtronic Business Overview
Table 88. Medtronic Product
Table 89. Medtronic Revenue in Tumor Ablation Business (2015-2020) (Million US$)
Table 90. Medtronic Recent Development
Table 91. Boston Scientific Company Details
Table 92. Boston Scientific Business Overview
Table 93. Boston Scientific Product
Table 94. Boston Scientific Revenue in Tumor Ablation Business (2015-2020) (Million US$)
Table 95. Boston Scientific Recent Development
Table 96. Galil Medical Company Details
Table 97. Galil Medical Business Overview
Table 98. Galil Medical Product
Table 99. Galil Medical Revenue in Tumor Ablation Business (2015-2020) (Million US$)
Table 100. Galil Medical Recent Development
Table 101. Neuwave Medical Company Details
Table 102. Neuwave Medical Business Overview
Table 103. Neuwave Medical Product
Table 104. Neuwave Medical Revenue in Tumor Ablation Business (2015-2020) (Million US$)
Table 105. Neuwave Medical Recent Development
Table 106. Misonix Company Details
Table 107. Misonix Business Overview
Table 108. Misonix Product
Table 109. Misonix Revenue in Tumor Ablation Business (2015-2020) (Million US$)
Table 110. Misonix Recent Development
Table 111. Merit Medical Company Details
Table 112. Merit Medical Business Overview
Table 113. Merit Medical Product
Table 114. Merit Medical Revenue in Tumor Ablation Business (2015-2020) (Million US$)
Table 115. Merit Medical Recent Development
Table 116. Sonacare Medical Business Overview
Table 117. Sonacare Medical Product
Table 118. Sonacare Medical Company Details
Table 119. Sonacare Medical Revenue in Tumor Ablation Business (2015-2020) (Million US$)
Table 120. Sonacare Medical Recent Development
Table 121. EDAP TMS Company Details
Table 122. EDAP TMS Business Overview
Table 123. EDAP TMS Product
Table 124. EDAP TMS Revenue in Tumor Ablation Business (2015-2020) (Million US$)
Table 125. EDAP TMS Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
Table 1. Tumor Ablation Key Market Segments
Table 2. Key Players Covered: Ranking by Tumor Ablation Revenue
Table 3. Ranking of Global Top Tumor Ablation Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Tumor Ablation Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Radiofrequency (RF) Ablation
Table 6. Key Players of Microwave Ablation
Table 7. Key Players of Cryoablation
Table 8. Key Players of Other Technologies
Table 9. COVID-19 Impact Global Market: (Four Tumor Ablation Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Tumor Ablation Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Tumor Ablation Players to Combat Covid-19 Impact
Table 14. Global Tumor Ablation Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Tumor Ablation Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Tumor Ablation Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Tumor Ablation Market Share by Regions (2015-2020)
Table 18. Global Tumor Ablation Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Tumor Ablation Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Tumor Ablation Market Growth Strategy
Table 24. Main Points Interviewed from Key Tumor Ablation Players
Table 25. Global Tumor Ablation Revenue by Players (2015-2020) (Million US$)
Table 26. Global Tumor Ablation Market Share by Players (2015-2020)
Table 27. Global Top Tumor Ablation Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tumor Ablation as of 2019)
Table 28. Global Tumor Ablation by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Tumor Ablation Product Solution and Service
Table 31. Date of Enter into Tumor Ablation Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Tumor Ablation Market Size by Type (2015-2020) (Million US$)
Table 34. Global Tumor Ablation Market Size Share by Type (2015-2020)
Table 35. Global Tumor Ablation Revenue Market Share by Type (2021-2026)
Table 36. Global Tumor Ablation Market Size Share by Application (2015-2020)
Table 37. Global Tumor Ablation Market Size by Application (2015-2020) (Million US$)
Table 38. Global Tumor Ablation Market Size Share by Application (2021-2026)
Table 39. North America Key Players Tumor Ablation Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Tumor Ablation Market Share (2019-2020)
Table 41. North America Tumor Ablation Market Size by Type (2015-2020) (Million US$)
Table 42. North America Tumor Ablation Market Share by Type (2015-2020)
Table 43. North America Tumor Ablation Market Size by Application (2015-2020) (Million US$)
Table 44. North America Tumor Ablation Market Share by Application (2015-2020)
Table 45. Europe Key Players Tumor Ablation Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Tumor Ablation Market Share (2019-2020)
Table 47. Europe Tumor Ablation Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Tumor Ablation Market Share by Type (2015-2020)
Table 49. Europe Tumor Ablation Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Tumor Ablation Market Share by Application (2015-2020)
Table 51. China Key Players Tumor Ablation Revenue (2019-2020) (Million US$)
Table 52. China Key Players Tumor Ablation Market Share (2019-2020)
Table 53. China Tumor Ablation Market Size by Type (2015-2020) (Million US$)
Table 54. China Tumor Ablation Market Share by Type (2015-2020)
Table 55. China Tumor Ablation Market Size by Application (2015-2020) (Million US$)
Table 56. China Tumor Ablation Market Share by Application (2015-2020)
Table 57. Japan Key Players Tumor Ablation Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Tumor Ablation Market Share (2019-2020)
Table 59. Japan Tumor Ablation Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Tumor Ablation Market Share by Type (2015-2020)
Table 61. Japan Tumor Ablation Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Tumor Ablation Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Tumor Ablation Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Tumor Ablation Market Share (2019-2020)
Table 65. Southeast Asia Tumor Ablation Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Tumor Ablation Market Share by Type (2015-2020)
Table 67. Southeast Asia Tumor Ablation Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Tumor Ablation Market Share by Application (2015-2020)
Table 69. India Key Players Tumor Ablation Revenue (2019-2020) (Million US$)
Table 70. India Key Players Tumor Ablation Market Share (2019-2020)
Table 71. India Tumor Ablation Market Size by Type (2015-2020) (Million US$)
Table 72. India Tumor Ablation Market Share by Type (2015-2020)
Table 73. India Tumor Ablation Market Size by Application (2015-2020) (Million US$)
Table 74. India Tumor Ablation Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Tumor Ablation Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Tumor Ablation Market Share (2019-2020)
Table 77. Central & South America Tumor Ablation Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Tumor Ablation Market Share by Type (2015-2020)
Table 79. Central & South America Tumor Ablation Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Tumor Ablation Market Share by Application (2015-2020)
Table 81. Angiodynamics Company Details
Table 82. Angiodynamics Business Overview
Table 83. Angiodynamics Product
Table 84. Angiodynamics Revenue in Tumor Ablation Business (2015-2020) (Million US$)
Table 85. Angiodynamics Recent Development
Table 86. Medtronic Company Details
Table 87. Medtronic Business Overview
Table 88. Medtronic Product
Table 89. Medtronic Revenue in Tumor Ablation Business (2015-2020) (Million US$)
Table 90. Medtronic Recent Development
Table 91. Boston Scientific Company Details
Table 92. Boston Scientific Business Overview
Table 93. Boston Scientific Product
Table 94. Boston Scientific Revenue in Tumor Ablation Business (2015-2020) (Million US$)
Table 95. Boston Scientific Recent Development
Table 96. Galil Medical Company Details
Table 97. Galil Medical Business Overview
Table 98. Galil Medical Product
Table 99. Galil Medical Revenue in Tumor Ablation Business (2015-2020) (Million US$)
Table 100. Galil Medical Recent Development
Table 101. Neuwave Medical Company Details
Table 102. Neuwave Medical Business Overview
Table 103. Neuwave Medical Product
Table 104. Neuwave Medical Revenue in Tumor Ablation Business (2015-2020) (Million US$)
Table 105. Neuwave Medical Recent Development
Table 106. Misonix Company Details
Table 107. Misonix Business Overview
Table 108. Misonix Product
Table 109. Misonix Revenue in Tumor Ablation Business (2015-2020) (Million US$)
Table 110. Misonix Recent Development
Table 111. Merit Medical Company Details
Table 112. Merit Medical Business Overview
Table 113. Merit Medical Product
Table 114. Merit Medical Revenue in Tumor Ablation Business (2015-2020) (Million US$)
Table 115. Merit Medical Recent Development
Table 116. Sonacare Medical Business Overview
Table 117. Sonacare Medical Product
Table 118. Sonacare Medical Company Details
Table 119. Sonacare Medical Revenue in Tumor Ablation Business (2015-2020) (Million US$)
Table 120. Sonacare Medical Recent Development
Table 121. EDAP TMS Company Details
Table 122. EDAP TMS Business Overview
Table 123. EDAP TMS Product
Table 124. EDAP TMS Revenue in Tumor Ablation Business (2015-2020) (Million US$)
Table 125. EDAP TMS Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Tumor Ablation Market Share by Type: 2020 VS 2026
Figure 2. Radiofrequency (RF) Ablation Features
Figure 3. Microwave Ablation Features
Figure 4. Cryoablation Features
Figure 5. Other Technologies Features
Figure 6. Global Tumor Ablation Market Share by Application: 2020 VS 2026
Figure 7. Liver Cancer Case Studies
Figure 8. Lung Cancer Case Studies
Figure 9. Kidney Cancer Case Studies
Figure 10. Others Case Studies
Figure 11. Tumor Ablation Report Years Considered
Figure 12. Global Tumor Ablation Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Tumor Ablation Market Share by Regions: 2020 VS 2026
Figure 14. Global Tumor Ablation Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Tumor Ablation Market Share by Players in 2019
Figure 17. Global Top Tumor Ablation Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tumor Ablation as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Tumor Ablation Revenue in 2019
Figure 19. North America Tumor Ablation Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Tumor Ablation Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Tumor Ablation Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Tumor Ablation Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Tumor Ablation Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Tumor Ablation Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Tumor Ablation Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Angiodynamics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Angiodynamics Revenue Growth Rate in Tumor Ablation Business (2015-2020)
Figure 28. Medtronic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Medtronic Revenue Growth Rate in Tumor Ablation Business (2015-2020)
Figure 30. Boston Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Boston Scientific Revenue Growth Rate in Tumor Ablation Business (2015-2020)
Figure 32. Galil Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Galil Medical Revenue Growth Rate in Tumor Ablation Business (2015-2020)
Figure 34. Neuwave Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Neuwave Medical Revenue Growth Rate in Tumor Ablation Business (2015-2020)
Figure 36. Misonix Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Misonix Revenue Growth Rate in Tumor Ablation Business (2015-2020)
Figure 38. Merit Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Merit Medical Revenue Growth Rate in Tumor Ablation Business (2015-2020)
Figure 40. Sonacare Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Sonacare Medical Revenue Growth Rate in Tumor Ablation Business (2015-2020)
Figure 42. EDAP TMS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. EDAP TMS Revenue Growth Rate in Tumor Ablation Business (2015-2020)
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed
Figure 1. Global Tumor Ablation Market Share by Type: 2020 VS 2026
Figure 2. Radiofrequency (RF) Ablation Features
Figure 3. Microwave Ablation Features
Figure 4. Cryoablation Features
Figure 5. Other Technologies Features
Figure 6. Global Tumor Ablation Market Share by Application: 2020 VS 2026
Figure 7. Liver Cancer Case Studies
Figure 8. Lung Cancer Case Studies
Figure 9. Kidney Cancer Case Studies
Figure 10. Others Case Studies
Figure 11. Tumor Ablation Report Years Considered
Figure 12. Global Tumor Ablation Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Tumor Ablation Market Share by Regions: 2020 VS 2026
Figure 14. Global Tumor Ablation Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Tumor Ablation Market Share by Players in 2019
Figure 17. Global Top Tumor Ablation Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tumor Ablation as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Tumor Ablation Revenue in 2019
Figure 19. North America Tumor Ablation Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Tumor Ablation Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Tumor Ablation Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Tumor Ablation Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Tumor Ablation Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Tumor Ablation Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Tumor Ablation Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Angiodynamics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Angiodynamics Revenue Growth Rate in Tumor Ablation Business (2015-2020)
Figure 28. Medtronic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Medtronic Revenue Growth Rate in Tumor Ablation Business (2015-2020)
Figure 30. Boston Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Boston Scientific Revenue Growth Rate in Tumor Ablation Business (2015-2020)
Figure 32. Galil Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Galil Medical Revenue Growth Rate in Tumor Ablation Business (2015-2020)
Figure 34. Neuwave Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Neuwave Medical Revenue Growth Rate in Tumor Ablation Business (2015-2020)
Figure 36. Misonix Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Misonix Revenue Growth Rate in Tumor Ablation Business (2015-2020)
Figure 38. Merit Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Merit Medical Revenue Growth Rate in Tumor Ablation Business (2015-2020)
Figure 40. Sonacare Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Sonacare Medical Revenue Growth Rate in Tumor Ablation Business (2015-2020)
Figure 42. EDAP TMS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. EDAP TMS Revenue Growth Rate in Tumor Ablation Business (2015-2020)
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed
